Results 11 to 20 of about 2,664,817 (408)

Fibrosis Progression Rate in Biopsy-proven Nonalcoholic Fatty Liver Disease among People with Diabetes versus People without Diabetes: A Multicenter Study.

Gastroenterology, 2023
BACKGROUND AND AIMS There are limited data regarding fibrosis progression in biopsy-proven nonalcoholic fatty liver disease (NAFLD), between people with type 2 diabetes mellitus (T2DM) versus people without T2DM.
Daniel Q. Huang, L. Wilson, Cynthia E. Behling, D. Kleiner, K. Kowdley, S. Dasarathy, Maral Amangurbanova, N. Terrault, A. Diehl, N. Chalasani, B. Neuschwander‐Tetri, A. Sanyal, J. Tonascia, R. Loomba   +13 more
semanticscholar   +1 more source

Liver biopsy for assessment of chronic liver diseases: a synopsis

Clinical and Experimental Medicine (Testo stampato), 2022
The world-wide increase in chronic liver disease (CLD) calls for refinement of diagnostic and prognostic measures for early and accurate disease detection and management.
A. Chowdhury, Kosha J. Mehta
semanticscholar   +1 more source

Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment

Frontiers in Medicine, 2021
An increasing percentage of people have or are at risk to develop non-alcoholic fatty liver disease (NAFLD) worldwide. NAFLD comprises different stadia going from isolated steatosis to non-alcoholic steatohepatitis (NASH).
Leen Heyens, D. Busschots, G. Koek, G. Robaeys, S. Francque   +4 more
semanticscholar   +1 more source

Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.

Journal of the American Medical Association (JAMA), 2021
Importance No therapy has been shown to reduce the risk of serious adverse outcomes in patients with nonalcoholic steatohepatitis (NASH). Objective To investigate the long-term relationship between bariatric surgery and incident major adverse liver ...
A. Aminian, Abbas Al-Kurd, Rickesha Wilson, J. Bena, Hana Fayazzadeh, Tavankit Singh, Vance L. Albaugh, F. Shariff, Noe A. Rodriguez, Jian Jin, S. Brethauer, S. Dasarathy, N. Alkhouri, P. Schauer, A. McCullough, S. Nissen   +15 more
semanticscholar   +1 more source

Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology

Gut, 2020
Liver biopsy is required when clinically important information about the diagnosis, prognosis or management of a patient cannot be obtained by safer means, or for research purposes.
J. Neuberger, J. Patel, H. Caldwell, S. Davies, Vanessa Hebditch, C. Hollywood, S. Hubscher, S. Karkhanis, W. Lester, N. Roslund, R. West, J. Wyatt, M. Heydtmann   +12 more
semanticscholar   +1 more source

Incidence of Complications from Percutaneous Biopsy in Chronic Liver Disease: A Systematic Review and Meta-Analysis

Digestive Diseases and Sciences, 2021
Background Approaches to liver biopsy have changed over the past decade in patients with chronic liver disease. Aims We conducted a systematic review and meta-analysis on the incidence of all complications and technical failure associated with ...
H. Thomaides-Brears, N. Alkhouri, D. Allende, M. Harisinghani, M. Noureddin, N. Reau, M. French, C. Pantoja, S. Mouchti, D. Cryer   +9 more
semanticscholar   +1 more source

The utility of liver biopsy in 2020.

Current Opinion in Gastroenterology, 2020
PURPOSE OF REVIEW Over the past decade, imaging modalities and serological tests have emerged as important tools in the evaluation of liver diseases, in many cases supplanting the use of liver biopsy and histological examination.
A. Khalifa, D. Rockey
semanticscholar   +1 more source

Primary hepatic lymphoma diagnosed using endoscopic ultrasound-guided liver biopsy: a case report

Journal of Medical Case Reports, 2021
Background Because of the rarity of primary hepatic lymphomas, diagnosis of this disease entity may often be difficult, and performing a liver biopsy is the only way to establish a definitive diagnosis. Recently, endoscopic ultrasound-guided liver biopsy
Kenichiro Nishikawa, Koji Katsuta, Syota Tanaka, Kodai Fujibe, Aiji Hattori, Yasunori Shiono, Michiaki Oiwa, Shimpei Matsusaki   +7 more
doaj   +1 more source

EUS-guided left lobe liver biopsy: Safer modality with similar diagnostic yield as right lobe: a pilot study

Endoscopy International Open, 2023
Background and study aims Percutaneous liver biopsy is traditionally done on the right lobe of the liver. Endoscopic ultrasound-guided liver biopsy (EUS-LB) can be performed on either the left or right lobe or as a combined bi-lobar biopsy.
Mithun Sharma, Sundeep Lakhtakia, Nitin Jagtap, Anuradha Sekaran, Rakesh Kalapala, Basha Jahangeer, Anand Kulkarni, Mohan Ramchandani, Rajesh Gupta, Swapna Samudraala, Juhi Khanna, Padaki Nagaraja, Sowmya Iyengar, Baker Ali Gora, Guduru Venkat Rao, Nageshwar Reddy   +15 more
doaj   +1 more source

Mortality in Biopsy-Confirmed Nonalcoholic Fatty Liver Disease

Gut, 2020
Objective Population-based data are lacking regarding the risk of overall and cause-specific mortality across the complete histological spectrum of non-alcoholic fatty liver disease (NAFLD).
Tracey G. Simon, B. Roelstraete, H. Khalili, H. Hagström, J. Ludvigsson   +4 more
semanticscholar   +1 more source